A Quiz Based On NEJM Scientific References Articles

15 Questions | Total Attempts: 147

SettingsSettingsSettings
Please wait...
Medicine Quizzes & Trivia

Welcome to October ESAT of Scientific references - C3


Questions and Answers
  • 1. 
    Full form of NEJM:
    • A. 

      New Exciting Journal of Medicine

    • B. 

      Non Entertaining Journal of Medicine

    • C. 

      New England Journal of Medicine

    • D. 

      New Epic Journal of Medicine

  • 2. 
    Study in NEJM was comparison of efficacy and treatment failure of:
    • A. 

      Amoxyclav and Dicloxacillin

    • B. 

      Amoxyclav and Placebo

    • C. 

      Amoxyclav and Ampicillin

    • D. 

      Amoxyclav and Cefixime

  • 3. 
    Objective of the study of Amoxyclav and Placebo - NEJM article is to:
    • A. 

      To evaluate the efficacy & rate of treatment failure in children less than 2 yrears of age, who were suffering from AOM.

    • B. 

      To evaluate the efficacy & rate of treatment failure in children less than 2 yrears of age, who were suffering from SSTI– NEJM article.

    • C. 

      To evaluate the efficacy & rate of treatment failure in children less than 2 yrears of age, who were suffering from UTI– NEJM article.

    • D. 

      To evaluate the efficacy & rate of treatment failure in children less than 2 yrears of age, who were suffering from RTI.

  • 4. 
    As per NEJM study of Amoxyclav and Placebo, ____________ % of symptoms was reduced with Amoxyclav on Day 8.
    • A. 

      70%

    • B. 

      100%

    • C. 

      90%

    • D. 

      80%

  • 5. 
    Full form of MIC:
    • A. 

      Minimum Inhibitory complex

    • B. 

      Maximum Inhibitory concentration

    • C. 

      Minimum Inhibitory concentration

    • D. 

      Minimum instant concentration

  • 6. 
    In MIC study of CEFI O, MIC of cefixime against salmonella Typhi was:
    • A. 

      0.9 mcg /ml

    • B. 

      .09 mcg /ml

    • C. 

      .9 mg/ml

    • D. 

      .09 mg/ml

  • 7. 
    MIC of cefixime was reduced to _________ after addition of ofloxacin against Salmonella Typhi:
    • A. 

      .01 mcg/ml

    • B. 

      .1 mcg/ml

    • C. 

      .01mg/ml

    • D. 

      .1 mg/ml

  • 8. 
    Against ____________ bacteria causing UTI the MIC of Ofloxacin was reduced by more than 5 times after addition of Cefixime.
    • A. 

      P aeruginosa

    • B. 

      E. Coli

    • C. 

      K. Pneumoniae

    • D. 

      Salmonella Typhi

  • 9. 
    Against E.Coli, the MIC of Ofloxacin was reduced by _______ times after addition of Cefixime & that of Cefixime was reduced by _________times after addition of Ofloxacin.
    • A. 

      5 & 2 times

    • B. 

      2 & 5 times

    • C. 

      2 & 2 times

    • D. 

      5 & 5 times

  • 10. 
    CEFI -L News letter topic is:
    • A. 

      UTI

    • B. 

      SSTI

    • C. 

      URTI

    • D. 

      LRTI

  • 11. 
    _________ is the LRTI highlighted in News Letter of CEFI O.
    • A. 

      Pneumonia

    • B. 

      CAP

    • C. 

      Bronchitis

    • D. 

      HAP

  • 12. 
    Objective of Finecef CV Study: To evaluate the efficacy & safety of fixed dose combination of Cefpodoxime + Potassium Clavulanate in comparison with Cefuroxime Axetil in patients with:
    • A. 

      Resistance

    • B. 

      LRTI

    • C. 

      URTI

    • D. 

      UTI

  • 13. 
    Conclusion of Finecef CV study - Clinical cure rates of Cefpodoxime with Clavulanic acid was:
    • A. 

      57%

    • B. 

      67%

    • C. 

      77%

    • D. 

      87%

  • 14. 
    Anafortan KOL Series Issue 4- Camylofin was tried on 4 year old patient suffering from:
    • A. 

      Functional Abdominal pain

    • B. 

      Functional Abdominal pain and Irritable Bowel Syndrome

    • C. 

      Irritable Bowel syndrome

    • D. 

      Abdominal pain due to Dysmennorhoea

  • 15. 
    The prevalence of weekly______________ in school going children ranges between 11 –38 % with 3.2 % reporting abdominal pain on a daily basis.
    • A. 

      Headache

    • B. 

      Bodyache

    • C. 

      Abdominal pain

    • D. 

      Diarhoea